New patent for Actelion drug OPSUMIT

Annual Drug Patent Expirations for OPSUMIT Opsumit is a drug marketed by Actelion and is included in one NDA. It is available from one supplier. There are four patents protecting…

The post New patent for Actelion drug OPSUMIT appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog